The global infection control market is driven by the growing need to prevent healthcare-associated infections, strengthen sterilization practices, and maintain hygiene standards across healthcare facilities. Hospitals, pharmaceutical manufacturers, diagnostic laboratories, and medical device companies increasingly rely on infection prevention products and services to protect patients and healthcare professionals. The market is also benefiting from stricter healthcare regulations, rising surgical volumes, and growing awareness of the importance of effective disinfection and sterilization. As healthcare infrastructure expands worldwide, infection control solutions are becoming essential for improving patient safety, minimizing contamination risks, and supporting quality healthcare delivery.

The global infection control market size was valued at USD 55.3 billion in 2025 and is projected to grow from USD 58.5 billion in 2026 to USD 90.0 billion by 2033, registering a CAGR of 6.4% from 2026 to 2033. North America dominated the market with a 47.2% revenue share in 2025, while the consumables segment accounted for the largest share of 60.7%. The hospital segment also held a substantial position, representing 40.3% of market revenue in 2025. 

Download a free sample copy of the Infection Control Market report to understand detailed coverage and inclusions in the final report 

Prominent Industry Trends

- Automation and Advanced Sterilization Technologies: Healthcare facilities are increasingly adopting advanced sterilization equipment, automated instrument reprocessing systems, and modern disinfection technologies. These solutions help improve processing efficiency, support consistent infection prevention procedures, and reduce the risk of contamination caused by manual handling.

- Outsourcing of Sterilization Services: Hospitals, pharmaceutical companies, and medical device manufacturers are increasingly considering specialized service providers for sterilization and infectious waste disposal. Outsourcing enables organizations to access technical expertise, manage operational expenses, and meet product safety and regulatory requirements.

- Growing Emphasis on Hospital-Acquired Infection Prevention: The prevention of healthcare-associated infections remains a major priority for healthcare providers. Demand for disinfectants, personal protective equipment, sterilization supplies, and infection monitoring procedures continues to be supported by efforts to improve patient safety and reduce infection-related complications.

- Expansion of Sustainable Infection Control Products: Manufacturers are exploring environmentally conscious disinfectants, improved waste management processes, and products designed to minimize environmental impact. These developments reflect the growing importance of combining effective infection prevention with responsible resource management.

Market Growth Drivers

Rising Prevalence of Healthcare-Associated Infections

Healthcare-associated infections represent a significant challenge for hospitals and other medical facilities. Patients may be exposed to infectious microorganisms during surgery, catheterization, intensive care treatment, and other medical procedures. These infections can increase treatment costs, extend hospital stays, and contribute to serious complications.

Consequently, healthcare providers are strengthening their infection prevention protocols through improved sterilization, surface disinfection, protective barriers, and medical instrument reprocessing. Growing attention to patient safety is expected to support the adoption of infection control products across healthcare settings.

Increasing Surgical and Clinical Procedures

The growing volume of surgical interventions and diagnostic procedures is another important factor supporting market expansion. Medical instruments must be properly cleaned, disinfected, or sterilized according to their intended use to minimize the risk of infection transmission.

As hospitals expand their surgical capacity and adopt advanced medical technologies, demand for sterilization equipment, disinfectants, and associated consumables is expected to increase. Complex instruments used in minimally invasive and robotic procedures also create a need for specialized cleaning and reprocessing solutions.

Stringent Healthcare Regulations and Standards

Healthcare organizations must follow established infection prevention, sterilization, and waste management requirements. Regulatory guidance and institutional protocols encourage the consistent use of appropriate disinfectants, validated sterilization processes, and protective equipment.

Compliance requirements also influence pharmaceutical manufacturing and medical device production, where contamination can compromise product safety and quality. These conditions create opportunities for manufacturers offering reliable equipment, validated processes, and specialized infection control services.

Market Segmentation Analysis

The global infection control market is segmented by type, end use, and region, reflecting the different products and services required to maintain hygienic and sterile environments. 

By Type

The market includes equipment, services, and consumables.

• Consumables: This segment accounted for 60.7% of revenue in 2025. Products include disinfectants, sterilization supplies, personal protective equipment, safety-enhanced medical devices, and infectious waste disposal-related consumables. Their recurring use across healthcare facilities contributes to sustained demand.

• Equipment: This category includes sterilization equipment, disinfectors, washers, endoscope reprocessors, and other specialized systems. Adoption is supported by the need for reliable instrument processing, efficient workflows, and consistent infection prevention.

• Services: Services include contract sterilization and infectious waste disposal. The segment is expected to grow at a CAGR of 8.6% from 2026 to 2033 as organizations seek specialized capabilities and greater operational efficiency.

By End Use

Hospitals, medical device companies, clinical laboratories, pharmaceutical companies, and other facilities represent the principal end-use categories.

Hospitals held the largest share at 40.3% in 2025 and are expected to remain an important source of demand. Hospitals require a broad range of infection control solutions across operating rooms, intensive care units, patient wards, and central sterile services departments.

Medical device companies depend on validated sterilization processes to prepare products for distribution. Clinical laboratories use disinfectants, protective supplies, and contamination prevention procedures to safeguard staff and samples. Pharmaceutical manufacturers require sterile production environments and effective cleaning procedures to maintain product quality.

Looking for more specific insights? Customize this report to suite your business needs

Regional Market Outlook

North America

North America dominated the global infection control market with a 47.2% revenue share in 2025. The region benefits from established healthcare infrastructure, strong awareness of healthcare-associated infections, and demand for technologically advanced sterilization and disinfection solutions.

The United States is a major contributor to regional demand. Investments in healthcare facilities, infection prevention programs, and medical technology development continue to support the adoption of infection control products and services.

Asia Pacific

Asia Pacific is projected to register the fastest regional growth, with a CAGR of 7.4% from 2026 to 2033. Healthcare infrastructure expansion, increasing medical expenditure, rising patient volumes, and growing awareness of hospital hygiene are important growth factors.

China, India, Japan, South Korea, and Australia represent significant markets for infection control solutions. In India, growing healthcare capacity and increasing emphasis on hygiene standards are creating opportunities for suppliers of sterilization equipment, disinfectants, and infection prevention services.

Europe and Other Regions

Europe represents an important market due to established healthcare systems, infection prevention initiatives, and demand for compliant medical equipment. Latin America and the Middle East and Africa also present growth opportunities as healthcare infrastructure develops and medical facilities increase their focus on patient safety.

Competitive Landscape

The infection control market features established medical technology companies and specialized service providers competing through product development, acquisitions, partnerships, and geographic expansion.

Key companies include:

• 3M

• Belimed AG

• O&M Halyard or its affiliates.

• GETINGE AB (publ) Corporate

• ASP

• MATACHANA

• Sterigenics U.S., LLC - A Sotera Health company

• MMM Group

• Medivators Inc.

• STERIS.

• Midmark Corporation.

• W&H

Competitive differentiation increasingly depends on equipment reliability, process validation, workflow efficiency, regulatory compliance, and customer support. Companies are also investing in technologies that help healthcare providers improve sterilization consistency and operational productivity.

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Explore U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database